Exploring the power of ZT Scan DIA

Feb 7, 2025 | Blogs, Life Science Research, Proteomics, ZenoTOF 7600+ system | 0 comments

Read time: 2 minutes

In a recent presentation, Tim Heymann from Mann Lab at the Max Planck Institute of Biochemistry shared his first impressions of ZT Scan DIA, the novel data-independent acquisition strategy from SCIEX, highlighting its innovative approach and significant benefits for proteomics research. Let’s dive into the key points from his insightful talk.

Understanding ZT Scan DIA

ZT Scan DIA offers a more efficient scan mode than regular SWATH DIA. The major difference lies in the continuous scan with overlapping windows, which eliminates overhead time and provides an additional Q1 scanning dimension. This results in a more efficient and detailed analysis, allowing researchers to distinguish between different precursors even if they appear to coelute.

Benchmarking ZT Scan DIA

Tim’s initial benchmarks focused on three performance assessments with a K562 digest: bulk-level analysis, lower sample inputs and short gradients. Using the Evosep One system coupled to the ZenoTOF 7600+ system, he tested various setups for higher coverage and throughput. The results were promising, showing a noticeable increase in identifications (IDs) at both the precursor and protein group levels.

Performance at different loads and gradients

ZT Scan DIA significantly boosted performance, especially at lower sample loads and shorter LC gradients. For instance, at 50 nanograms, there was a 50% gain in protein IDs, and at 500 SPD, the increase in quantifiable precursors was almost 100%. This robust performance across different settings highlights the versatility and efficiency of ZT Scan DIA.

Insights into phosphoproteomics

When analyzing phosphopeptides, ZT Scan DIA showed more than 10% gains in phosphosite detections, particularly in the lower abundant range. Although the overlap with Zeno SWATH DIA was lower, this was expected due to the enrichment process in phosphoproteomics. The enhanced selectivity of ZT Scan DIA provides more confidence in identifying phosphosites.

Leveraging AlphaDIA and Transfer Learning for data processing

Tim also discussed using AlphaDIA and Transfer Learning to maximize data analysis. By adapting models to different patterns and setups, AlphaDIA can significantly improve identification rates. Although current limitations prevent full access to the Q1 scanning dimension, ongoing developments promise even better performance in the future.

Conclusion

Overall, ZT Scan DIA represents a substantial advancement in proteomics research. It offers a performance boost that becomes more pronounced at lower loads and faster gradients. With its innovative approach and robust results, ZT Scan DIA is poised to impact the field significantly.

Watch Tim’s presentation here

Related links:

Technical overview: Continuing the data-independent acquisition (r)evolution: Introducing ZT Scan DIA for quantitative proteomics

Nature Portfolio article: Fast, sensitive or accurate? Proteomics researchers can now have all three.

Sterile but toxic: Cereulide detection in food matrices

In a recent webinar, Ming Gao, Ph.D., Senior Research Chemist at Mérieux NutriSciences, explored the growing challenge of cereulide contamination in food products and the analytical strategies needed to detect this heat-stable toxin at trace levels. The session examined how LC-MS/MS can help laboratories overcome the limitations of traditional microbiological screening and meet emerging regulatory requirements.

How SCIEX Now empowers mass spec users to work with more control, clarity and confidence

In this interview, Andy Wilcox, Senior Market Development Manager, Aftermarket and Software, speaks with Susanna Baqué, Senior Director of Global Customer Experience, about how SCIEX Now gives customers one connected digital workspace to manage instruments, reduce time spent searching for information, resolve issues faster and keep their laboratory running more efficiently and with greater confidence.

Bioanalysis across modalities: Advancing confident decisions with modern LC‑MS strategies

As therapeutic pipelines continue to diversify, bioanalysis is being asked to do more than ever before. From small molecules to complex biologics, today’s scientists must generate high‑quality, reliable data across a growing range of molecule types and workflows, often under increasing time pressure.

Posted by

I developed a foundational understanding of biochemistry during my undergraduate studies before gaining a masters in molecular and cellular biophysics, and finally obtaining my Ph.D conducting in-depth proteomics research in peanut allergy. I started at SCIEX in the applications support team, later being promoted to the application lead for life science research in EMEAI. I am currently leading global strategic marketing efforts, contributing to the advancement of small molecule OMICS. This role is pivotal in bridging the gap between scientific innovation and market demand, ensuring that products and workflows not only meet the needs of the market but also stand out in a competitive landscape.

0 Comments

Submit a Comment

Pin It on Pinterest

Share This

Share this post with your network